Compared to controls, significantly more SLE patients were seropositive for EBV-VCA IgA (37% vs 17%; p = 0.018) and EBV-EA IgG (39% vs 13%; p = 0.0011) (Fig. 1). This evidence concerns the gene CD79A and systemic lupus erythematosus.